These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 2654960

  • 1. Platelet function, platelet prostanoids and vascular prostacyclin in diabetes mellitus.
    Hendra T, Betteridge DJ.
    Prostaglandins Leukot Essent Fatty Acids; 1989 Mar; 35(4):197-212. PubMed ID: 2654960
    [No Abstract] [Full Text] [Related]

  • 2. Platelet-endothelial cell interactions. Metabolic maps of structures and actions of prostaglandins, prostacyclin, thromboxane and cyclic AMP.
    Nalbandian RM, Henry RL.
    Semin Thromb Hemost; 1978 Mar; 5(2):87-111. PubMed ID: 216078
    [No Abstract] [Full Text] [Related]

  • 3. Prostacyclin, thromboxane A2 interactions in haemostasis and thrombosis.
    Moncada S, Amezcua JL.
    Haemostasis; 1979 Mar; 8(3-5):252-65. PubMed ID: 389758
    [Abstract] [Full Text] [Related]

  • 4. Interrelationships between prostacyclin and thromboxane A2.
    Moncada S, Vane JR.
    Ciba Found Symp; 1980 Mar; 78():165-83. PubMed ID: 6258879
    [Abstract] [Full Text] [Related]

  • 5. Thromboxane and prostacyclin in disease: a review.
    Halushka PV, Dollery CT, MacDermot J.
    Q J Med; 1983 Mar; 52(208):461-70. PubMed ID: 6361838
    [No Abstract] [Full Text] [Related]

  • 6. Insulin and arachidonic acid metabolism in diabetes mellitus.
    Halushka PV, Mayfield R, Colwell JA.
    Metabolism; 1985 Dec; 34(12 Suppl 1):32-6. PubMed ID: 3934501
    [Abstract] [Full Text] [Related]

  • 7. The platelet-perfused in-vitro heart: an alternative model for studying the role of endogenous prostacyclin and thromboxane in control of coronary perfusion.
    Köhler P, Schrör K.
    Basic Res Cardiol; 1981 Dec; 76(5):463-7. PubMed ID: 7030300
    [Abstract] [Full Text] [Related]

  • 8. Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes.
    Hung SC, Ghali NI, Venton DL, Le Breton GC.
    Biochim Biophys Acta; 1983 Feb; 728(2):171-8. PubMed ID: 6219702
    [Abstract] [Full Text] [Related]

  • 9. Plasma thromboxane and prostacyclin metabolite ratio in atherosclerosis and diabetes mellitus.
    Udvardy M, Török I, Rak K.
    Thromb Res; 1987 Aug 15; 47(4):479-84. PubMed ID: 3116717
    [Abstract] [Full Text] [Related]

  • 10. Platelets and atherosclerosis.
    Weksler BB, Nachman RL.
    Am J Med; 1981 Sep 15; 71(3):331-3. PubMed ID: 7025618
    [No Abstract] [Full Text] [Related]

  • 11. Interaction of albumin, arachidonic acid and prostanoids in platelets.
    Purdon AD, Rao AK.
    Prostaglandins Leukot Essent Fatty Acids; 1989 Mar 15; 35(4):213-8. PubMed ID: 2654961
    [No Abstract] [Full Text] [Related]

  • 12. Mass spectrometric identification of urinary and plasma metabolites of 9-hydroxy-19,20-bis-nor-prostanoic acid (rosaprostol).
    Benfenati E, Fanelli R, Chiabrando C, Valcavi U, Bosone E, Farina P.
    Prostaglandins; 1988 May 15; 35(5):665-84. PubMed ID: 3399677
    [Abstract] [Full Text] [Related]

  • 13. Biological properties of prostacyclin-thromboxane system.
    Blaskó G.
    Ther Hung; 1984 May 15; 32(2):45-51. PubMed ID: 6443751
    [No Abstract] [Full Text] [Related]

  • 14. Are the vascular complications of diabetes mellitus preceded by an altered thromboxane/prostacyclin plasmatic ratio?
    Tomasi V, Strano A, Orlandi M, Bartolini G, Davì G, Monti D, Taddeo U, Zavagli G.
    Med Hypotheses; 1986 Mar 15; 19(3):229-41. PubMed ID: 3007948
    [Abstract] [Full Text] [Related]

  • 15. Platelet function and thrombus in diabetes.
    Viinikka L.
    Acta Endocrinol Suppl (Copenh); 1985 Mar 15; 272():31-4. PubMed ID: 3914801
    [Abstract] [Full Text] [Related]

  • 16. Prostacyclin and thromboxane A2 release in isolated rat lungs.
    Korbut R, Boyd J, Eling T.
    Prostaglandins; 1982 Jan 15; 23(1):67-75. PubMed ID: 7038777
    [Abstract] [Full Text] [Related]

  • 17. Thromboxane and prostacyclin: implications for function and disease of the vasculature.
    McGiff JC.
    Adv Intern Med; 1980 Jan 15; 25():199-216. PubMed ID: 6987841
    [No Abstract] [Full Text] [Related]

  • 18. Prostanoids in neonatology.
    Kääpä P.
    Ann Clin Res; 1984 Jan 15; 16(5-6):330-4. PubMed ID: 6398667
    [No Abstract] [Full Text] [Related]

  • 19. Anti-aggregatory prostanoids. Part I.
    Korbut R, Gryglewski RJ.
    Acta Physiol Pol; 1985 Jan 15; 36(5-6):293-302. PubMed ID: 3915631
    [Abstract] [Full Text] [Related]

  • 20. Prostacyclin potentiates 13-azaprostanoic acid-induced platelet deaggregation.
    Parise LV, Venton DL, Le Breton GC.
    Thromb Res; 1982 Dec 15; 28(6):721-30. PubMed ID: 6301090
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.